Trademark Search  /  BELMONITOR COV-2

BELMONITOR COV-2

● Live · Registered

U.S. federal trademark · Serial No. 79305894 · Reg. No. 6720755

Mark
BELMONITOR COV-2
Status
Registered
Serial Number
79305894
Registration No.
6720755
Filing Date
December 22, 2020
Registration Date
May 24, 2022
Class(es)
Class 005, Class 010

Owners

Rainer Böhnke
01 · DE
Rainer Böhnke
01 · DE
Rainer Böhnke
01 · DE
PharmACT Holding AG
24 · CH
PharmACT Holding AG
24 · CH
PharmACT Holding AG
24 · CH

Goods & Services

Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections

Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "BELMONITOR COV-2" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.